FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Zipperle Cynthia H 2. Issuer Name and Ticker or Trading Symbol HUMANA INC [ HUM ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
SVP, Chief Acct Officer & Cont
(Last)         (First)         (Middle)
HUMANA INC., 500 WEST MAIN ST
3. Date of Earliest Transaction (MM/DD/YYYY)
3/26/2020
(Street)
LOUISVILLE, KY 40202
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Humana Common                 3162  D 
 
Humana Common                 896  I  See Footnote (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2)  (2)                  (4)  (4) Humana Common  302    302  D 
 
Restricted Stock Units (2)  (2)                  (5)  (5) Humana Common  745    745  D 
 
Restricted Stock Units (2)  (2)                  (6)  (6) Humana Common  542    542  D 
 
Restricted Stock Units (3)  (3)                  (7)  (7) Humana Common  713    713  D 
 
Phantom Stock Units (8)  (8) 3/26/2020    J     11       (8)  (8) Humana Common  11  $304.48  280  I  See Footnote (8)

Explanation of Responses:
(1)  Shares held for the benefit of reporting person as of February 28, 2020 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
(2)  Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
(3)  Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
(4)  Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20.
(5)  Restricted stock units granted to reporting person on 02/19/18, 100% of the award is vesting on 02/19/21.
(6)  Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21.
(7)  Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
(8)  Phantom Stock Units held for the benefit of reporting person as of March 26, 2020 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Zipperle Cynthia H
HUMANA INC.
500 WEST MAIN ST
LOUISVILLE, KY 40202


SVP, Chief Acct Officer & Cont

Signatures
Cynthia H. Zipperle 3/30/2020
**Signature of Reporting Person Date
Humana (NYSE:HUM)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Humana Charts.
Humana (NYSE:HUM)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Humana Charts.